You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cell Lines

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fibroblast-Derived Cell Lines From Skin Biopsies of

Enrolling by invitation
  • Primary Immunodeficiency
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 18, 2023

    Healthy Participants Trial in Daytona Beach, Madison (Eptinezumab Mammalian Cell Line, Eptinezumab Yeast Cell Line)

    Completed
    • Healthy Participants
    • Eptinezumab Mammalian Cell Line
    • Eptinezumab Yeast Cell Line
    • Daytona Beach, Florida
    • +1 more
    Aug 25, 2022

    Periodontal Attachment Loss Trial in Bengaluru (extracorporeal shockwave device, Fibroblast cell lines not subjected to

    Completed
    • Periodontal Attachment Loss
    • extracorporeal shockwave device
    • Fibroblast cell lines not subjected to shockwaves from extracorporeal shockwave device
    • Bengaluru, Karnataka, India
      Krishnadevaraya College of Dental Science and Hospital
    Mar 2, 2023

    Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder, Lymphoma Trial in Montreal (Group A, Group B)

    Recruiting
    • Epstein-Barr Virus Infections
    • +2 more
    • Group A
    • Group B
    • Montreal, Quebec, Canada
      Hôpital Maisonneuve-Rosemont
    Apr 5, 2022

    Viral Infections After HSCT Trial in Washington (VSTs)

    Active, not recruiting
    • Viral Infections After HSCT
    • VSTs
    • Washington, District of Columbia
      Childrens National Medical Center
    Aug 30, 2022

    Cell Collection to Study Eye Diseases

    Recruiting
    • Retinal Disease
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Explanted Lung Tissues With Pulmonary Fibrosis

      Recruiting
      • Pulmonary Fibrosis
        • Chicago, Illinois
          The University of Chicago
        Nov 18, 2022

        Learn About First and Later Lines of Medicines in Treating

        Completed
        • Metastatic Renal Cell Carcinoma
          • New York, New York
            Pfizer Headquarters
          May 12, 2023

          Small Cell Lung Cancer Trial (Tarlatamab)

          Available
          • Small Cell Lung Cancer
          • (no location specified)
          Sep 26, 2023

          Stem Cells in NF1 Tumors of the Central Nervous System

          Suspended
          • Neurofibromatosis Type 1
          • Tumors of the Central Nervous System
          • Collection of Stem Cells
          • Washington, District of Columbia
            Children's National Medical Center
          Mar 8, 2022

          Utility of Primary Glioblastoma Cell Lines

          Recruiting
          • Tumor
          • Brain Tumor
            • Pozzilli, IS, Italy
              Neuromed IRCCS
            Apr 9, 2021

            Models in Neuroendocrine Neoplasm

            Recruiting
            • Neuroendocrine Neoplasm
            • Biopsy, open or laparoscopic surgery
            • Shanghai, Shanghai, China
              Department of Pancreatic Surgery, Fudan University Shanghai Canc
            Sep 19, 2021

            Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)

            Recruiting
            • Adenovirus Infection
            • +6 more
            • Virus-specific Cytotoxic T-lymphocytes
            • Houston, Texas
              M D Anderson Cancer Center
            Jan 6, 2023

            Generation of Antigen-specific T-lymphocyte Cell Lines From

            Terminated
            • Healthy
            • Leukapheresis
            • New York, New York
              Memorial Sloan Kettering Cancer Center
            Feb 2, 2021

            Small Cell Lung Cancer Trial in Beijing (Chiauranib, Placebo)

            Recruiting
            • Small Cell Lung Cancer
            • Beijing, Beijing, China
              Cancer Hospital, Chinese Academy of Medical Sciences
            May 4, 2022

            Carcinoma, Non-small Cell Lung Trial in Changsha (ethaselen)

            Completed
            • Carcinoma, Non-small Cell Lung
            • Changsha, Hunan, China
              Hunan province tumor hospital
            Mar 1, 2022

            Multiple Myeloma in Relapse Trial in Finland, Sweden (Carfilzomib for Inj 60 milligram (MG), Elotuzumab 400 MG, Dexamethasone)

            Active, not recruiting
            • Multiple Myeloma in Relapse
            • Carfilzomib for Inj 60 milligram (MG)
            • +2 more
            • Helsinki, Finland
            • +7 more
            Mar 14, 2022

            Multiple Myeloma Trial (Pembrolizumab)

            Withdrawn
            • Multiple Myeloma
            • (no location specified)
            Apr 20, 2022

            Cancer of Prostate, Cancer of the Prostate, Tumors, Prostate Trial in Pittsburgh (androgen ablation (AA), DC1 vaccine)

            Completed
            Has Results
            • Cancer of Prostate
            • +6 more
            • androgen ablation (AA)
            • DC1 vaccine
            • Pittsburgh, Pennsylvania
              University of Pittsburgh Cancer institute
            Oct 13, 2020

            Gustatory Cell Lines in Patients Operated on for Cancer of

            Completed
            • Cancer of the Tongue
            • Sample of cancerous epithelium from the tongue
            • Dijon, France
              Chu Dijon Bourgogne
            Sep 14, 2020

            NSCLC (NSCLC) Trial in China (Capmatinib)

            Recruiting
            • Non-Small Cell Lung Cancer (NSCLC)
            • Xiamen, Fujian, China
            • +18 more
            Jan 27, 2023

            Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

            Recruiting
            • Recurrent Plasma Cell Myeloma
            • Refractory Plasma Cell Myeloma
            • Des Moines, Iowa
            • +8 more
            Jan 12, 2023

            Multiple Myeloma Trial in Beijing, Jiang Su Province (Belantamab mafodotin)

            Completed
            • Multiple Myeloma
            • Belantamab mafodotin
            • Beijing, China
            • +2 more
            Feb 8, 2022

            AIDS, BK Virus Infection, Human Immunodeficiency Virus Trial in Houston (Allogeneic BK-specific Cytotoxic T-lymphocytes,

            Recruiting
            • Acquired Immunodeficiency Syndrome
            • +7 more
            • Allogeneic BK-specific Cytotoxic T-lymphocytes
            • Laboratory Biomarker Analysis
            • Houston, Texas
              M D Anderson Cancer Center
            Oct 29, 2021

            Multiple Myeloma in Relapse, Refractory Multiple Myeloma Trial in China, Taiwan (TJ202 and Dexamethasone)

            Active, not recruiting
            • Multiple Myeloma in Relapse
            • Refractory Multiple Myeloma
            • TJ202 and Dexamethasone
            • Beijing, Beijing, China
            • +17 more
            Oct 17, 2022